Article Details
Retrieved on: 2024-10-23 21:08:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The comparative effectiveness study found that the addition of selexipag (Uptravi) to double oral therapy (DOT) reduced the risk of patients being ...
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here